Metronomic chemotherapy following the maximum tolerated dose is an effective anti-tumour therapy affecting angiogenesis, tumour dissemination and cancer stem cells
出版年份 2013 全文链接
标题
Metronomic chemotherapy following the maximum tolerated dose is an effective anti-tumour therapy affecting angiogenesis, tumour dissemination and cancer stem cells
作者
关键词
-
出版物
INTERNATIONAL JOURNAL OF CANCER
Volume 133, Issue 10, Pages 2464-2472
出版商
Wiley
发表日期
2013-05-07
DOI
10.1002/ijc.28259
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Tumors That Acquire Resistance to Low-Dose Metronomic Cyclophosphamide Retain Sensitivity to Maximum Tolerated Dose Cyclophosphamide
- (2015) Urban Emmenegger et al. NEOPLASIA
- Clinical, pharmacokinetic and pharmacodynamic evaluations of metronomic UFT and cyclophosphamide plus celecoxib in patients with advanced refractory gastrointestinal cancers
- (2012) Giacomo Allegrini et al. ANGIOGENESIS
- Rapid Decrease in Delivery of Chemotherapy to Tumors after Anti-VEGF Therapy: Implications for Scheduling of Anti-Angiogenic Drugs
- (2012) Astrid A.M. Van der Veldt et al. CANCER CELL
- Residual dormant cancer stem-cell foci are responsible for tumor relapse after antiangiogenic metronomic therapy in hepatocellular carcinoma xenografts
- (2012) Ines Martin-Padura et al. LABORATORY INVESTIGATION
- Phase I Study of Oral Gemcitabine Prodrug (LY2334737) Alone and in Combination with Erlotinib in Patients with Advanced Solid Tumors
- (2011) Stijn L.W. Koolen et al. CLINICAL CANCER RESEARCH
- Cyclophosphamide-based metronomic chemotherapy: After 10 years of experience, where do we stand and where are we going?
- (2011) Nicolas Penel et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Metronomic scheduling of anticancer treatment: the next generation of multitarget therapy?
- (2011) Nicolas André et al. Future Oncology
- Activity of a multitargeted chemo-switch regimen (sorafenib, gemcitabine, and metronomic capecitabine) in metastatic renal-cell carcinoma: a phase 2 study (SOGUG-02-06)
- (2010) Joaquim Bellmunt et al. LANCET ONCOLOGY
- Metronomic Gemcitabine in Combination with Sunitinib Inhibits Multisite Metastasis and Increases Survival in an Orthotopic Model of Pancreatic Cancer
- (2010) H. S. Tran Cao et al. MOLECULAR CANCER THERAPEUTICS
- Pancreatic cancer stem cells - update and future perspectives
- (2010) Enza Lonardo et al. Molecular Oncology
- Metronomic chemotherapy: new rationale for new directions
- (2010) Eddy Pasquier et al. Nature Reviews Clinical Oncology
- Combined Targeted Treatment to Eliminate Tumorigenic Cancer Stem Cells in Human Pancreatic Cancer
- (2009) Maria–Theresa Mueller et al. GASTROENTEROLOGY
- Pancreatic Cancer Stem Cells
- (2008) Cheong J. Lee et al. JOURNAL OF CLINICAL ONCOLOGY
- Antiangiogenic effect of gemcitabine following metronomic administration in a pancreas cancer model
- (2008) B. Laquente et al. MOLECULAR CANCER THERAPEUTICS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started